Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mass spectrometric analysis of mono- and dialkyl ethers of diols.

Lipids·2016
Same author

Mass spectrometric analysis of long chain alk-1-enyl ether esters and alkyl ether esters of diols.

Lipids·2016
Same author

Identification and analysis of wax esters by mass spectrometry.

Lipids·2016
Same author

Essential fatty acid deficient rats fed hydrogenated oil -A response.

Lipids·2016
Same author

Mass spectrometric determination of positions of double bonds in polyunsaturated fatty acid pyrrolidides.

Lipids·2016
Same author

Collisional activation of a series of homoconjugated octadecadienoic acids with fast atom bombardment and tandem mass spectrometry.

Journal of the American Society for Mass Spectrometry·2013

Related Experiment Video

Updated: May 2, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.9K

Influence of hyperalimentation on rat hepatic microsomal fluidity and function.

R G Knodell1, D I Whitmer, R T Holman

  • 1Division of Gastroenterology, University of Maryland/Baltimore VA Medical Center.

Gastroenterology
|May 1, 1990
PubMed
Summary

Total parenteral nutrition alters rat liver microsomal membrane fluidity and lipid composition. However, these changes do not fully explain the observed decreases in hepatic drug metabolism during parenteral nutrition.

More Related Videos

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

6.4K
Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

3.3K

Related Experiment Videos

Last Updated: May 2, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.9K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

6.4K
Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

3.3K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Hepatology

Background:

  • Parenteral nutrition (PN) can reduce hepatic drug metabolism compared to enteral nutrition or standard chow.
  • Hepatic microsomal membrane fluidity and lipid composition are known to affect liver enzyme activity.

Purpose of the Study:

  • To investigate the impact of parenteral and enteral nutrition on rat hepatic microsomal membrane fluidity and lipid composition.
  • To compare these changes with their effects on hepatic drug metabolism, specifically meperidine demethylase and ethoxyresorufin deethylase activities.

Main Methods:

  • Assessing hepatic microsomal membrane fluidity using fluorescence anisotropy.
  • Analyzing lipid composition of hepatic microsomes.
  • Measuring activities of drug-metabolizing enzymes (meperidine demethylase, ethoxyresorufin deethylase).
  • Comparing outcomes between rats receiving PN, enteral nutrition, and chow.

Main Results:

  • Both PN and enteral nutrition significantly decreased microsomal membrane fluidity.
  • PN significantly decreased meperidine demethylase activity, while enteral nutrition reduced ethoxyresorufin deethylase activity.
  • Supplementing PN with lipids normalized membrane fluidity and lipid profiles but did not restore meperidine demethylase activity.

Conclusions:

  • Parenteral and enteral nutrition induce significant alterations in the physical state and lipid composition of rat hepatic microsomal membranes.
  • These observed changes in membrane properties are not the primary cause of the altered hepatic drug metabolism during hyperalimentation.